News

“Our results suggest that light measures don’t work, and strong measures do," said Charles Courtemanche.

The ambitious study is organized into six phases, beginning with the basic preparations and leading into actual implementation and monitoring of various evidence-based strategies to reduce opioid deaths.

For the RAPID project, the team will create a membrane mask and other flat sheet materials with a more porous and spongy structure that will include charged domain and enzymes, which would capture and effectively deactivate SARS-CoV-2, the virus that causes COVID-19.

UK Physics and Astronomy has received its first Research Experiences for Undergraduates (REU) grant from the National Science Foundation (NSF). This highly competitive program will help provide research opportunities for students from regional colleges.

Through the “Fall into Fitness” walking and diabetes education program that she leads, Castle has reached hundreds of her fellow community members, facilitating diabetes screening and education.

Started in the summer of 2016, Markey Women Strong comprises philanthropic women and men who aim to make a meaningful difference in cancer research by funding female researchers focused on advancing the fight against cancer at the University of Kentucky.

NSF Fellows receive a three-year annual stipend of $34,000 along with a $12,000 cost of education allowance for tuition and fees for a research-based master's or doctoral degree in a STEM (science, technology, engineering or mathematics) field.

A group of UK professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).

UK researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. The research is part of UK’s CURE Alliance team, which is uniting UK researchers across disciplines in the fight against the novel coronavirus.

“We are pleased to be able to offer this clinical trial to patients with COVID-19 in Kentucky. While there is no standard treatment for COVID-19, this trial gives us the ability to test multiple therapies rapidly in order to identify the most promising agents.”